Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
CALL
Skywest
SKYW
$4.02B
| $638K | ﹤0.01% |
7,300
-800
| -10% | -$81.8K |
|
2127
United Bankshares
UBSI
$6.46B
| $638K | ﹤0.01% |
18,390
+13,017
| +242% | +$477K |
|
2128
CALL
Main Street Capital
MAIN
$5.47B
| $633K | ﹤0.01% |
11,200
+6,100
| +120% | +$363K |
|
2129
Oil States International
OIS
$506M
| $632K | ﹤0.01% |
122,719
+89,343
| +268% | +$469K |
|
2130
Amphastar Pharmaceuticals
AMPH
$935M
| $632K | ﹤0.01% |
+21,793
| New | +$696K |
|
2131
PUT
Altria Group
MO
$114B
| $630K | ﹤0.01% |
10,500
-149,700
| -93% | -$8.17M |
|
|
DVAX
2132
DELISTED
Dynavax Technologies
DVAX
| $629K | ﹤0.01% |
48,467
-15,991
| -25% | -$212K |
|
2133
CALL
Li Auto
LI
$12B
| $627K | ﹤0.01% |
24,900
+9,500
| +62% | +$245K |
|
2134
PUT
Impinj
PI
$5.08B
| $626K | ﹤0.01% |
6,900
+1,400
| +25% | +$157K |
|
2135
Alliant Energy
LNT
$17.7B
| $626K | ﹤0.01% |
+9,721
| New | +$594K |
|
2136
MediaAlpha
MAX
$787M
| $623K | ﹤0.01% |
+67,447
| New | +$720K |
|
2137
CALL
ODDITY Tech
ODD
$655M
| $623K | ﹤0.01% |
14,400
+1,900
| +15% | +$84.4K |
|
2138
CALL
OSI Systems
OSIS
$3.25B
| $622K | ﹤0.01% |
3,200
+400
| +14% | +$76.2K |
|
2139
CALL
Bank of America
BAC
$437B
| $622K | ﹤0.01% |
14,900
-353,900
| -96% | -$15.8M |
|
2140
Wave Life Sciences
WVE
$1.03B
| $622K | ﹤0.01% |
+76,926
| New | +$841K |
|
|
WCC
2141
CALL
WESCO International
WCC
$16.5B
| $621K | ﹤0.01% |
+4,000
| New | +$716K |
|
2142
PUT
Air Products & Chemicals
APD
$67.7B
| $619K | ﹤0.01% |
+2,100
| New | +$648K |
|
2143
GoodRx Holdings
GDRX
$1.19B
| $619K | ﹤0.01% |
+140,338
| New | +$659K |
|
2144
CALL
Onto Innovation
ONTO
$17.8B
| $619K | ﹤0.01% |
+5,100
| New | +$859K |
|
2145
Azenta
AZTA
$1.45B
| $618K | ﹤0.01% |
+17,832
| New | +$821K |
|
2146
PUT
Everest Group
EG
$14.4B
| $618K | ﹤0.01% |
1,700
+500
| +42% | +$177K |
|
2147
Vanda Pharmaceuticals
VNDA
$329M
| $617K | ﹤0.01% |
134,431
+109,813
| +446% | +$512K |
|
2148
PUT
Corcept Therapeutics
CORT
$13.4B
| $617K | ﹤0.01% |
+5,400
| New | +$329K |
|
2149
Prospect Capital
PSEC
$1.2B
| $617K | ﹤0.01% |
+150,395
| New | +$647K |
|
2150
AMERISAFE
AMSF
$485M
| $615K | ﹤0.01% |
11,712
-13,021
| -53% | -$660K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.